NDDS in Cancer Therapy

NDDS in Cancer Therapy

Global NDDS in Cancer Therapy Market to Reach $65.4 Billion by 2030
In the changed post COVID-19 business landscape, the global market for NDDS in Cancer Therapy estimated at US$14.4 Billion in the year 2022, is projected to reach a revised size of US$65.4 Billion by 2030, growing at aCAGR of 20.9% over the period 2022-2030. Nanoparticles, one of the segments analyzed in the report, is projected to record 20.8% CAGR and reach US$60.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Embolization Particles segment is readjusted to a revised 22.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $4.3 Billion, While China is Forecast to Grow at 19.8% CAGR
The NDDS in Cancer Therapy market in the U.S. is estimated at US$4.3 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$10.9 Billion by the year 2030 trailing a CAGR of 19.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 18.7% and 17.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 14.5% CAGR.

Select Competitors (Total 46 Featured) -

  • 20Med Therapeutics
  • Acuitas Therapeutics
  • AD Particles
  • Ademtech SA
  • Advanced NanoTechnology Lab
  • Advanced NanoTherapies Inc.
  • ADVANO
  • Alpha-O Peptides AG
  • Applied Nanoparticles
  • Avidea Technologies
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
NDDS in Cancer Therapy – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World NDDS in Cancer Therapy Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for NDDS in Cancer Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 3: World Historic Review for NDDS in Cancer Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 4: World 16-Year Perspective for NDDS in Cancer Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Nanoparticles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 6: World Historic Review for Nanoparticles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 7: World 16-Year Perspective for Nanoparticles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Embolization Particles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 9: World Historic Review for Embolization Particles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 10: World 16-Year Perspective for Embolization Particles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
III. MARKET ANALYSIS
UNITED STATES
NDDS in Cancer Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
TABLE 11: USA Recent Past, Current & Future Analysis for NDDS in Cancer Therapy by Type - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 12: USA Historic Review for NDDS in Cancer Therapy by Type - Nanoparticles and Embolization Particles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 13: USA 16-Year Perspective for NDDS in Cancer Therapy by Type - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2014, 2023 & 2030
CANADA
TABLE 14: Canada Recent Past, Current & Future Analysis for NDDS in Cancer Therapy by Type - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 15: Canada Historic Review for NDDS in Cancer Therapy by Type - Nanoparticles and Embolization Particles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 16: Canada 16-Year Perspective for NDDS in Cancer Therapy by Type - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2014, 2023 & 2030
JAPAN
NDDS in Cancer Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
TABLE 17: Japan Recent Past, Current & Future Analysis for NDDS in Cancer Therapy by Type - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 18: Japan Historic Review for NDDS in Cancer Therapy by Type - Nanoparticles and Embolization Particles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 19: Japan 16-Year Perspective for NDDS in Cancer Therapy by Type - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2014, 2023 & 2030
CHINA
NDDS in Cancer Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
TABLE 20: China Recent Past, Current & Future Analysis for NDDS in Cancer Therapy by Type - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 21: China Historic Review for NDDS in Cancer Therapy by Type - Nanoparticles and Embolization Particles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 22: China 16-Year Perspective for NDDS in Cancer Therapy by Type - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2014, 2023 & 2030
EUROPE
NDDS in Cancer Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
TABLE 23: Europe Recent Past, Current & Future Analysis for NDDS in Cancer Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 24: Europe Historic Review for NDDS in Cancer Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 25: Europe 16-Year Perspective for NDDS in Cancer Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
TABLE 26: Europe Recent Past, Current & Future Analysis for NDDS in Cancer Therapy by Type - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 27: Europe Historic Review for NDDS in Cancer Therapy by Type - Nanoparticles and Embolization Particles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 28: Europe 16-Year Perspective for NDDS in Cancer Therapy by Type - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2014, 2023 & 2030
FRANCE
NDDS in Cancer Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
TABLE 29: France Recent Past, Current & Future Analysis for NDDS in Cancer Therapy by Type - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 30: France Historic Review for NDDS in Cancer Therapy by Type - Nanoparticles and Embolization Particles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 31: France 16-Year Perspective for NDDS in Cancer Therapy by Type - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2014, 2023 & 2030
GERMANY
NDDS in Cancer Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
TABLE 32: Germany Recent Past, Current & Future Analysis for NDDS in Cancer Therapy by Type - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 33: Germany Historic Review for NDDS in Cancer Therapy by Type - Nanoparticles and Embolization Particles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 34: Germany 16-Year Perspective for NDDS in Cancer Therapy by Type - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2014, 2023 & 2030
ITALY
TABLE 35: Italy Recent Past, Current & Future Analysis for NDDS in Cancer Therapy by Type - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 36: Italy Historic Review for NDDS in Cancer Therapy by Type - Nanoparticles and Embolization Particles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 37: Italy 16-Year Perspective for NDDS in Cancer Therapy by Type - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2014, 2023 & 2030
UNITED KINGDOM
NDDS in Cancer Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
TABLE 38: UK Recent Past, Current & Future Analysis for NDDS in Cancer Therapy by Type - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 39: UK Historic Review for NDDS in Cancer Therapy by Type - Nanoparticles and Embolization Particles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 40: UK 16-Year Perspective for NDDS in Cancer Therapy by Type - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2014, 2023 & 2030
REST OF EUROPE
TABLE 41: Rest of Europe Recent Past, Current & Future Analysis for NDDS in Cancer Therapy by Type - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 42: Rest of Europe Historic Review for NDDS in Cancer Therapy by Type - Nanoparticles and Embolization Particles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 43: Rest of Europe 16-Year Perspective for NDDS in Cancer Therapy by Type - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2014, 2023 & 2030
ASIA-PACIFIC
NDDS in Cancer Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
TABLE 44: Asia-Pacific Recent Past, Current & Future Analysis for NDDS in Cancer Therapy by Type - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 45: Asia-Pacific Historic Review for NDDS in Cancer Therapy by Type - Nanoparticles and Embolization Particles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 46: Asia-Pacific 16-Year Perspective for NDDS in Cancer Therapy by Type - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2014, 2023 & 2030
REST OF WORLD
TABLE 47: Rest of World Recent Past, Current & Future Analysis for NDDS in Cancer Therapy by Type - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 48: Rest of World Historic Review for NDDS in Cancer Therapy by Type - Nanoparticles and Embolization Particles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 49: Rest of World 16-Year Perspective for NDDS in Cancer Therapy by Type - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2014, 2023 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings